V. Fauveau

发表

Hepatic Glucokinase Is Required for the Synergistic Action of ChREBP and SREBP-1c on Glycolytic and Lipogenic Gene Expression*

M. Magnuson, J. Girard, F. Foufelle, 2004, Journal of Biological Chemistry.

Diet and Gastrointestinal Bypass–Induced Weight Loss

Megan E. Drew, B. Viollet, R. Batterham, 2011, Diabetes.

HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

Steve Kaye, Francoise Brun-Vezinet, Rob Schuurman, 1997, The Lancet.

Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice

J. Girard, F. Foufelle, R. Dentin, 2006, Diabetes.

GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.

M. Ziol, V. Baud, K. Billot, 2014, Endocrinology.

Loss of intestinal ChREBP impairs absorption of dietary sugars and prevents glycemic excursion curves

B. Tavitian, M. le Gall, R. Dentin, 2021, bioRxiv.

Growth factor receptor binding protein 14 inhibition triggers insulin‐induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma

M. Vasseur-Cognet, C. Desbois-Mouthon, M. Caüzac, 2017, Hepatology.

The Transcription Factor COUP-TFII Is Negatively Regulated by Insulin and Glucose via Foxo1- and ChREBP-Controlled Pathways

M. Vasseur-Cognet, T. Kitamura, C. Magnan, 2008, Molecular and Cellular Biology.

The role of chicken ovalbumin upstream promoter transcription factor II in the regulation of hepatic fatty acid oxidation and gluconeogenesis in newborn mice.

M. Vasseur-Cognet, J. Pégorier, V. Fauveau, 2015, American journal of physiology. Endocrinology and metabolism.

Maintenance of red blood cell integrity by AMP‐activated protein kinase α1 catalytic subunit

B. Viollet, M. Foretz, F. Andris, 2010, FEBS letters.

The MODY1 Gene for Hepatocyte Nuclear Factor 4 (cid:2) and a Feedback Loop Control COUP-TFII Expression in Pancreatic Beta Cells (cid:1)

M. Vasseur-Cognet, C. Wollheim, D. Scott, 2008 .

Alternative splicing of hepatitis B virus: A novel virus/host interaction altering liver immunity.

V. Fauveau, M. Maini, D. Kremsdorf, 2017, Journal of hepatology.

A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response

W. Wahli, H. Guillou, Edwin Fouché, 2017, Cell reports.

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice.

B. Viollet, M. Foretz, F. Andreelli, 2008, Cell metabolism.

Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.

J. Girard, V. Fauveau, V. Lenoir, 2012, Journal of hepatology.

LKB1 as a Gatekeeper of Hepatocyte Proliferation and Genomic Integrity during Liver Regeneration.

B. Viollet, N. Boussetta, M. Foretz, 2018, Cell reports.

Insulin resistance per se drives early and reversible dysbiosis-mediated gut barrier impairment and bactericidal dysfunction

M. Caüzac, A. Burnol, F. Benhamed, 2022, Molecular metabolism.

AMPKα1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expression.

B. Viollet, M. Foretz, V. Fauveau, 2014, Journal of hepatology.

The MODY1 Gene for Hepatocyte Nuclear Factor 4α and a Feedback Loop Control COUP-TFII Expression in Pancreatic Beta Cells

M. Vasseur-Cognet, C. Wollheim, D. Scott, 2008, Molecular and Cellular Biology.

Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance

H. Guillou, M. Komatsu, M. Caüzac, 2016, Molecular and Cellular Biology.

Diet and Gastrointestinal Bypass–Induced Weight Loss: The Roles of Ghrelin and Peptide YY

Megan E. Drew, B. Viollet, R. Batterham, 2011 .